Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-12

Clinical Trial Update: Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in Women [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Vitamin E plus mefenamic acid versus mefenamic acid alone for primary dysmenorrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MEFENAMIC ACID (Mefenamic acid)
  • Vitamin E (tocopherol)

Snippet

Sponsor: Nishtar Medical University | Conditions: Dysmenorrhea Primary, Vitamin E | Phase 4 | Status: COMPLETED